Clinical Trials

380 enrolled

Phase 2 Not yet recruiting

Nasopharyngeal Carcinoma

NCT07476287 2026-03-17

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

40 enrolled

Phase 1/2 Not yet recruiting

Lung Neoplasms, Small Cell Lung Carcinoma

NCT07477444 2026-03-17

HER-OIC

29 enrolled

Phase 3 Not yet recruiting

Gastroesophageal Cancer

NCT07477808 2026-03-17

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

116 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03424005 2026-03-16

Morpheus-panBC

Phase 1/2 Recruiting

792 enrolled

Breast Neoplasms

NCT03785574 2026-03-16

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Phase NA Recruiting

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT06538038 2026-03-16

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Recruiting

538 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06540066 2026-03-16

A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Phase 1 Terminated

35 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06731478 2026-03-16

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

726 enrolled

Stomach Neoplasms

NCT07472153 2026-03-16

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Phase 2/3 Recruiting

120 enrolled

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT07472478 2026-03-16

GIVEN

32 enrolled

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

596 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT05935098 2026-03-13

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

Phase 1 Terminated

99 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07471815 2026-03-13

Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy

Phase 2 Active not recruiting

Triple Negative Breast Neoplasms

NCT05763199 2026-03-12

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

20 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT07457528 2026-03-11

Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC

46 enrolled

Esophageal Squamous Cell Carcinoma

NCT05378334 2026-03-10

Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients

Phase NA Recruiting

82 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06408116 2026-03-10

PEGASUS

Esophageal Neoplasms

NCT07209189 2026-03-09

(NeoScorch HN)

75 enrolled

Phase NA Active not recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT01928589 2026-03-06

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

81 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT04262466 2026-03-06

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

410 enrolled

Other solid neoplasm

Select Advanced Solid Tumors

NCT04302025 2026-03-06

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

99 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

Phase 2 Suspended

126 enrolled

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07454226 2026-03-06

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07454720 2026-03-06

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Phase 2/3 Not yet recruiting

165 enrolled

Locally Advanced Resectable Rectal Cancer

NCT04575935 2026-03-05

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

580 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06596473 2026-03-05

A Study of BG-C477 in Participants With Advanced Solid Tumors

310 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07042438 2026-03-05

Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells

56 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT07452003 2026-03-05

An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC

Phase NA Recruiting

GastrointestinalGynecologic

Carcinoma, Non-Small-Cell Lung

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

Recruiting

20 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms

NCT05673148 2026-03-04

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

364 enrolled

Colorectal Neoplasms

NCT05981703 2026-03-04

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

217 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06177067 2026-03-04

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Other hematologic neoplasm

24 enrolled

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT06803680 2026-03-04

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

90 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT04703244 2026-03-03

Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

Recruiting

999 enrolled

Breast Neoplasms

NCT04975516 2026-03-03

Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer

Phase 2 Terminated

3 enrolled

Pancreatic Neoplasms

NCT05214482 2026-03-03

A Study of AK112 in Advanced Malignant Tumors

Phase 1/2 Completed

154 enrolled

Advanced Malignant Tumors

NCT06719700 2026-03-03

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

47 enrolled

Small Cell Lung Carcinoma

NCT07447570 2026-03-03

Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

27 enrolled

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT05710328 2026-03-02

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

235 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT07342283 2026-03-02

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer

Phase 3 Active not recruiting

Triple Negative Breast Neoplasms

NCT04928807 2026-02-27

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

231 enrolled

Rectal Neoplasms

NCT06578247 2026-02-27

QuANTUM-WILD

Other hematologic neoplasm

700 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT07033819 2026-02-27

Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib

48 enrolled

Ovarian Neoplasms

NCT07437898 2026-02-27

Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study

42 enrolled

Phase 3 Active not recruiting

Esophageal Squamous Cell Carcinoma

NCT03774732 2026-02-25

NIRVANA-LUNG

327 enrolled

Phase EARLY_PHASE1 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03943173 2026-02-25

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

15 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04798664 2026-02-25

Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Phase NA Completed

3,228 enrolled 41 charts

Phase 3 Not yet recruiting

Lung Neoplasms, Tobacco Use Disorder, Smoking Cessation

NCT07432087 2026-02-25

Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

246 enrolled